Showing results (171-180 of 242) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patientsFederico Cappuzzo, Marileila Varella-Garcia, Hisayuki Shigematsu, et al.Molecular Pharmacology|October 14, 2008
Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cellsLindsay Marek, Kathryn E Ware, Alexa Fritzsche, et al.Molecular Cancer Therapeutics|May 16, 2003
Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survivalClark M Whitehead, Keith A Earle, John Fetter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancerPuneeth Iyengar, Brian D Kavanagh, Zabi Wardak, et al.Clinical Lung Cancer|May 28, 2026
High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase InhibitorsYunan Nie, Alyse Staley, Trista K Hinz, et al.Hypertension (Dallas, Tex. : 1979)|July 2, 2008
Efficacy and safety of the Angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 yearsJoseph T Flynn, Kevin E C Meyers, Jose Pacheco Neto, et al.Lung Cancer (Amsterdam, Netherlands)|July 19, 2005
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypiaTimothy C Kennedy, Wilbur A Franklin, Sheila A Prindiville, et al.The Oncologist|February 28, 2015
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancerMarina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, et al.Plos One|December 19, 2013
Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancerKurtis D Davies, Sakshi Mahale, David P Astling, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2018
ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic EventsTerry L Ng, Derek E Smith, Rao Mushtaq, et al.Pageof 25